Cargando…
Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study
OBJECTIVE: Our previous metabolomics study showed that the plasma nervonic acid levels were higher in patients with major depressive disorder (MDD) than those in healthy controls and patients with bipolar disorder (BD). To examine whether the nervonic acid levels differ in the central nervous system...
Autores principales: | Kageyama, Yuki, Deguchi, Yasuhiko, Hattori, Kotaro, Yoshida, Sumiko, Goto, Yu‐ichi, Inoue, Koki, Kato, Tadafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035447/ https://www.ncbi.nlm.nih.gov/pubmed/33599392 http://dx.doi.org/10.1002/brb3.2075 |
Ejemplares similares
-
Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study
por: Kageyama, Yuki, et al.
Publicado: (2017) -
PS71. A Clinical Pilot Study of Plasma Mitochondrial DNA as a Biomarker for Bipolar Disorder
por: Kageyama, Yuki, et al.
Publicado: (2016) -
Increased cerebrospinal fluid fibrinogen in major depressive disorder
por: Hattori, Kotaro, et al.
Publicado: (2015) -
Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort
por: Nagata, Yuki, et al.
Publicado: (2018) -
Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder
por: Gotoh, Leo, et al.
Publicado: (2019)